BioPharma Dive 2025-12-18 Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition
BioPharma Dive 2025-12-18 Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding
BioPharma Dive 2025-12-17 Peanut allergy patch succeeds in late-stage study 5 years after FDA rejection
BioPharma Dive 2025-12-17 Addition emerges with $100M to make gene therapies for chronic and rare diseases
BioPharma Dive 2025-12-16 Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study
BioPharma Dive 2025-12-15 How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress